BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33335022)

  • 21. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
    Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
    Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study.
    van de Pol JAA; George L; van den Brandt PA; Baldewijns MMLL; Schouten LJ
    Int J Cancer; 2021 Jan; 148(1):67-76. PubMed ID: 32638386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutrition and renal cell cancer.
    Wolk A; Lindblad P; Adami HO
    Cancer Causes Control; 1996 Jan; 7(1):5-18. PubMed ID: 8850431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupation as a risk factor for renal cell cancer: a nationwide, prospective epidemiological study.
    Mariusdottir E; Ingimarsson JP; Jonsson E; Einarsson GV; Aspelund T; Gudnason V; Gudbjartsson T
    Scand J Urol; 2016 Jun; 50(3):181-5. PubMed ID: 26999634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort.
    Daniel CR; Park Y; Chow WH; Graubard BI; Hollenbeck AR; Sinha R
    Am J Clin Nutr; 2013 May; 97(5):1036-43. PubMed ID: 23515007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
    Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
    Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifetime Body Weight Trajectories and Risk of Renal Cell Cancer: A Large U.S. Prospective Cohort Study.
    Deng Z; Hajihosseini M; Moore JX; Khan S; Graff RE; Bondy ML; Chung BI; Langston ME
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1651-1659. PubMed ID: 37624040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.
    Rai BP; Luis Dominguez Escrig J; Vale L; Kuusk T; Capoun O; Soukup V; Bruins HM; Yuan Y; Violette PD; Santesso N; van Rhijn BWG; Hugh Mostafid A; Imran Omar M
    Eur Urol; 2022 Aug; 82(2):182-192. PubMed ID: 35393159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol consumption and risk of renal cell carcinoma: a prospective study of Swedish women.
    Rashidkhani B; Akesson A; Lindblad P; Wolk A
    Int J Cancer; 2005 Dec; 117(5):848-53. PubMed ID: 15957170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
    Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
    Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of alcohol consumption and renal cell carcinoma risk.
    Karami S; Daugherty SE; Purdue MP
    Int J Cancer; 2015 Jul; 137(1):238-42. PubMed ID: 25431248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body size and renal cell cancer incidence in a large US cohort study.
    Adams KF; Leitzmann MF; Albanes D; Kipnis V; Moore SC; Schatzkin A; Chow WH
    Am J Epidemiol; 2008 Aug; 168(3):268-77. PubMed ID: 18544571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary Acrylamide Is Not Associated with Renal Cell Cancer Risk in the CPS-II Nutrition Cohort.
    McCullough ML; Hodge RA; Um CY; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):616-619. PubMed ID: 30420439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection.
    Filocamo MT; Zanazzi M; Li Marzi V; Guidoni L; Villari D; Dattolo E; Nicita G
    Transplant Proc; 2009 Dec; 41(10):4197-201. PubMed ID: 20005368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.
    Zheng T; Zhu C; Bassig BA; Liu S; Buka S; Zhang X; Truong A; Oh J; Fulton J; Dai M; Li N; Shi K; Qian Z; Boyle P
    Int J Epidemiol; 2019 Dec; 48(6):1886-1896. PubMed ID: 31317187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study.
    Liu W; Park Y; Purdue MP; Giovannucci E; Cho E
    Cancer Causes Control; 2013 Oct; 24(10):1865-73. PubMed ID: 23868221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol consumption, tobacco smoking, and subsequent risk of renal cell carcinoma: The JPHC study.
    Minami T; Inoue M; Sawada N; Yamaji T; Iwasaki M; Tsugane S
    Cancer Sci; 2021 Dec; 112(12):5068-5077. PubMed ID: 34490717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of smoking, hypertension and lifestyle factors on kidney cancer - perspectives for prevention and screening programmes.
    Campi R; Rebez G; Klatte T; Roussel E; Ouizad I; Ingels A; Pavan N; Kara O; Erdem S; Bertolo R; Capitanio U; Mir MC
    Nat Rev Urol; 2023 Nov; 20(11):669-681. PubMed ID: 37328546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
    Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
    Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.
    Correa AF; Jegede O; Haas NB; Flaherty KT; Pins MR; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Dutcher JP; DiPaola RS; Carducci MA; Uzzo RG
    J Clin Oncol; 2019 Aug; 37(23):2062-2071. PubMed ID: 31216227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.